ChampionX (CHX) to Release Quarterly Earnings on Tuesday

ChampionX (NASDAQ:CHXGet Rating) is scheduled to release its earnings data after the market closes on Tuesday, April 26th. Analysts expect ChampionX to post earnings of $0.21 per share for the quarter. ChampionX has set its Q1 2022 guidance at EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

ChampionX (NASDAQ:CHXGet Rating) last released its quarterly earnings data on Wednesday, February 9th. The company reported $0.26 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.24 by $0.02. The company had revenue of $822.15 million during the quarter, compared to the consensus estimate of $834.63 million. ChampionX had a net margin of 3.68% and a return on equity of 7.34%. During the same period last year, the firm earned $0.07 EPS. On average, analysts expect ChampionX to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

CHX opened at $25.50 on Tuesday. The business has a 50 day simple moving average of $23.41. The company has a market cap of $5.18 billion, a P/E ratio of 47.22 and a beta of 3.00. ChampionX has a 12 month low of $18.26 and a 12 month high of $30.48. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.14 and a current ratio of 1.82.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 29th. Investors of record on Friday, April 8th will be issued a $0.075 dividend. This represents a $0.30 annualized dividend and a yield of 1.18%. The ex-dividend date is Thursday, April 7th. ChampionX’s dividend payout ratio (DPR) is presently 55.56%.

A number of institutional investors have recently made changes to their positions in CHX. BlackRock Inc. boosted its stake in shares of ChampionX by 0.7% during the 4th quarter. BlackRock Inc. now owns 24,374,728 shares of the company’s stock valued at $492,615,000 after purchasing an additional 179,749 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in ChampionX by 30.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,095,028 shares of the company’s stock worth $82,760,000 after acquiring an additional 946,759 shares in the last quarter. Wells Fargo & Company MN raised its holdings in ChampionX by 3.0% in the fourth quarter. Wells Fargo & Company MN now owns 742,283 shares of the company’s stock worth $15,000,000 after buying an additional 21,432 shares during the last quarter. Morgan Stanley raised its holdings in ChampionX by 131.1% in the second quarter. Morgan Stanley now owns 647,324 shares of the company’s stock worth $16,604,000 after buying an additional 367,241 shares during the last quarter. Finally, Sei Investments Co. raised its holdings in shares of ChampionX by 23.4% during the fourth quarter. Sei Investments Co. now owns 589,917 shares of the company’s stock valued at $11,921,000 after purchasing an additional 111,721 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

CHX has been the topic of several recent analyst reports. Bank of America cut shares of ChampionX from a “buy” rating to a “neutral” rating in a research note on Friday, March 11th. The Goldman Sachs Group upgraded shares of ChampionX from a “sell” rating to a “neutral” rating and set a $24.00 target price on the stock in a research note on Tuesday, February 22nd. Finally, Piper Sandler upgraded shares of ChampionX from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $28.00 to $30.00 in a research report on Monday, April 11th. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $28.33.

About ChampionX (Get Rating)

ChampionX Corporation provides chemistry solutions, and engineered equipment and technologies to oil and gas companies worldwide. The company's Production Chemical Technologies segment offers onshore and offshore chemical solutions, such as corrosion inhibitors, scale inhibitors, emulsion breakers, and biocides to oil and natural gas production and midstream markets to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment, and water-related issues.

Read More

Earnings History for ChampionX (NASDAQ:CHX)

Receive News & Ratings for ChampionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChampionX and related companies with MarketBeat.com's FREE daily email newsletter.